George S.

George S. serves as the Director of Global Program Management at Gilead Sciences, where a key achievement includes playing a pivotal role in the launch of the first approved drug to treat COVID-19. In this position since January 2023, George directly reports to the senior leadership team and oversees Virology, Respiratory, and Pandemic Preparedness programs to ensure alignment with strategic business priorities. Prior experience includes a senior consulting role at IPM Integrated Project Management Company, where George supported corporate strategic planning and partnered with executives in the pharmaceutical and biotech industries. George's career also includes managerial roles at Cherkottu Pvt Ltd and GSK, complemented by academic credentials that include an MBA from The University of Chicago Booth School of Business, an MS in Biotechnology from Abertay University, and a BTech in Biotechnology from Biju Patnaik University of Technology.